New PET tracer shows promise for uPAR-targeted therapy of neuroendocrine neoplasms
A novel PET radiotracer can accurately assess the presence of a biomarker that indicates the level of tumor aggressiveness in neuroendocrine neoplasms (NENs). According to research published in the September issue of the ...
Sep 28, 2022
0
0